Q4 2013

Filed Apr 14, 2014 · 10-K · 104 days after period end · 0001477932-14-001677

Q4 2013 · 10-K

derived · Computed from the longer spans the company filed.

Revenue—

Net Income

-$3.50M

derivedN/M vs Q4 2012

EPS, diluted—Not derived. Share counts vary by quarter.

Gross Profitderived-$460,429N/M

Same quarter

Metric	Q4 2013derived from reported figures	Q4 2012derived from reported figures	Q4 2011derived from reported figures	Q4 2010derived from reported figures
Revenue	—	$364.10K	$93.57K	—
Net Income	-$3.50M	-$307.20K	-$253.66K	—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

BioCorRx Inc. · CIK 1443863 · Engraved from SEC EDGAR